CYBB and glucose metabolism disease: Recent evidence suggests that the NOX2 isoenzyme, specifically expressed by microglia, may play a key regulatory role in ROS production after SE and glucose metabolism disorders during epilepticism (Fabisiak and Patel, 2022).